Intensive Lipid Lowering Treatment in Patients With Non-ST-elevation ACS Undergoing Percutaneous Coronary Intervention.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Atorvastatin (Primary)
- Indications Acute coronary syndromes
- Focus Therapeutic Use
- Acronyms ILLEPE-ACS
- 14 Jun 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 01 Apr 2011 Planned End Date changed from 1 Jul 2011 to 1 Nov 2011 as reported by ClinicalTrials.gov.
- 01 Apr 2011 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.